Ehud Marom – Chairman of the Board
Mr. Marom serves as Chairman of the board at PharmaTwoB. In addition, Mr. Marom is Chairman of the board & CEO at Stem Cell Medicine and Mapi Pharma.
He brings vast experience in management, operations, business and strategic planning in the pharmaceutical industry, where he held the positions over the years. Past positions include VP of Operations at Teva Pharmaceuticals’ API and Innovative divisions, where he was credited for his contribution to the market success of Teva; COO of Peptor Ltd; CEO of the Jerusalem-based biotechnology company, Gamida Cell, a leader in hematopoietic (blood) stem cell therapeutics; President and CEO of Makhteshim Chemical Works Ltd., followed by position of Senior VP of Supply Chain at Makhteshim-Agan Group.
Mr. Marom holds B.Sc. with distinction in Chemical Engineering from the Technion – Israel Institute of Technology.
Mrs. Liquornik is a senior Partner at Meitar Liquornik Geva Leshem Tal – Israel’s leading international law firm. Mrs. Liquornik represents corporations in a broad range of international and domestic corporate and commercial transactions, with emphasis on mergers and acquisitions, private equity financings, venture capital, information and communications technology transactions, outsourcing and advisory work. Maya has substantial experience in structuring and negotiating complex cross border technology and outsourcing transactions. Maya’s practice focuses on representing large publicly traded corporations, technology companies in various stages of development, venture capital and private equity funds and other corporate and investment banking clients. Prior to joining Meitar, Maya was an associate at Weil, Gotshal & Manges in New York. Mrs. Liquornik holds B.A.and LL.B. with Honors, from Tel Aviv University, Israel.
Dr. Itamar Borowitz is Managing Partner of Crossroad VC, the high-tech investment arm of the Generali Insurance Group in Israel and Chairman of the China Israel Innovation Center in Futain District, Shenzhen, China. Dr. Borowitz is the Chairman of Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem. He is a member of the Advisory Board of GLL Real Estate Partners GmBH. In the years 1992-2001 Dr. Borowitz was the CEO of the Phoenix Insurance Group, the Israel’s second largest insurance company, and in the years 1998-2001 the Chairman of the Israeli Insurance Association. Dr. Borowitz is a member of the Board of Governors of the of Tel Aviv University and member of the Board of Governors of the Hebrew University in Jerusalem, where he also serves as a member of the Funds Committee and of the Investment Committee. Dr. Borowitz holds a PhD in Physics, and an MBA and a B.A. in General History from Tel Aviv University
Mr. Kindler is Chief Executive Officer of Centrexion Therapeutics; Executive Chairman of vTv Therapeutics; a Venture Partner at Lux Capital; Global Chair of the GLG Institute; and a Managing Director at Starboard Capital Partners. Mr. Kindler serves on the boards of a number of publicly and privately held health care companies as well as several not-for-profit institutions. From 2006 to 2010, Mr. Kindler was the Chairman and Chief Executive Officer of Pfizer Inc. Prior to his appointment as Pfizer’s CEO, Mr. Kindler served as Pfizer’s Executive Vice President and General Counsel as well as a Vice Chairman of the company.Prior to joining Pfizer in 2002, he was Chairman of Boston Market Corporation from 2000 to 2001 and President of the Partner Brands group of McDonalds Corporation during 2001. Mr. Kindler holds a bachelor’s degree from Tufts University Summa Cum Laude and a J.D. from Harvard Law School Summa Cum Laude.
Dr. Schindel is the Co-Founder & Managing Partner of aMoon Fund since 2016. aMoon is a Healthcare & Life Science Investment Platform which is a partnership between Dr. Yair Schindel and Mr. Marius Nacht the Co-Founder and Chairman of the Israeli cyber security giant Check Point. Prior to aMoon Dr. Schindel was the Founding CEO of the Government’s National Digital Bureau “Digital Israel” at the Prime Minister’s Office and the first Chief Digital Officer of the State of Israel. Prior to Digital Israel Dr. Schindel was the CEO of Start-up Nation Central (SNC) aimed at accelerating Israeli innovation and entrepreneurship through deeper connections and co-innovation between Israel and the world. Prior to that Dr. Schindel was an investor, board member and advisory board member in several successful healthcare start-ups in the fields of devices, mobile health and big-data analytics including OmniGuide Inc. Zebra Medical Vision & Medisafe. Prior to that Dr. Schindel was Co-founder & CEO of MAOZ, a non-profit focusing on developing senior leadership for the Israeli public & social sectors. Before his business career Dr. Schindel served for 5 years in Israeli special forces as a combat medical officer, the last two years as the Chief Medical Officer for the Israeli Navy Seals unit “Shayetet 13”. Dr. Schindel holds an MBA from Harvard Business School and B.Sc.and MD degrees from the Goldman Medical School, Ben-Gurion University in Beer-Sheba, Israel.
Mr. Jonas is the founder, president and Chief Executive Officer of JVC Investment Partners LLC, a firm that provides private investment and strategic support in the healthcare space. Mr. Jonas founded PharMEDium Healthcare Corporation (industry’s leader and preeminent provider of hospital sterile compounding services for IV and Epidural therapies, a $10 billion market in the USA.)and was its Chairman and Chief Executive Officer. Prior to founding JVC Investment Partners and PharMEDium, Mr. Jonas held a number of senior management position with Baxter including its co-founder of Renal Therapy Services Worldwide Inc. He serves and served on a number of privately held companies and not for profit organizations. Mr. Jonas holds B.Sc and MBA from Roosevelt University, Chicago Illinois.
Mr. Kronfeld is the Chairman of JK&B Capital, L.L.C., a venture capital firm, which he founded in 1995. Prior thereto he served as a General Partner at Boston Capital Ventures, the Vice President of Acquisitions and Venture Investments at Ameritech, a Senior Manager at Booz Allen & Hamilton and a Systems Analyst at Electronic Data Systems. Since February 2010, Mr. Kronfeld has been a director, and a member of the compensation committee, of Dynasil Corporation of America (NASDAQ-GM:DYSL). Mr.Kronfeld holds MS in Computer Science from Stevens Institute of Technology and MBA from Wharton Business School.